Qualtrics
Share:
Trend Report Analysis: How Pharma Leaders Can Optimize for AI Adoption
The 2026 Market Research Trends Report highlights a fundamental shift from AI adoption to AI orchestration, where competitive advantage is driven by how effectively organizations integrate AI across the research lifecycle. AI agents are democratizing access to insights, enabling stakeholders beyond research teams to self-serve data and accelerate decision-making. At the same time, leading organizations are moving away from fragmented, general-purpose tools toward purpose-built platforms that unify data, analysis, and insight generation. The rise of synthetic data is further expanding what research can achieve allowing teams to test more ideas earlier, reduce costs, and increase speed. Organizations that fail to evolve risk losing strategic influence and budget. Responsory’s takeaway: Pharmaceutical organizations must reposition insights as a strategic growth driver, not a support function. This means enabling commercial, marketing, and medical teams with faster, self-service access to insights, while elevating research teams into strategic partners who guide high-impact decisions like launch planning and brand positioning.
